← Back to Clinical Trials
Recruiting NCT06638723

NCT06638723 Enhancing Motor Function in Individuals with Lower Limb Amputation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06638723
Status Recruiting
Phase
Sponsor University of Nevada, Las Vegas
Condition Amputation
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2023-06-30
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Balance and fall recovery training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2023-06-30 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overall goal of this research project is to investigate the effectiveness and the science of peer-based prosthetic skill training in individuals with leg amputation. Our belief is that amputee learners will show improved skill learning when observing demonstrations from other amputees, as opposed to observing nonamputee models. The investigators will accomplish the objective by answering the following two questions: Question 1: Does peer-based observation training works better for learning motor tasks for individuals with lower limb amputation (LLA)? Question 2: Are there differences in visual focus, behavior, and brain activation patterns when observing motor task demonstrations from amputee peers vs. non-amputees? Participants of this study will be asked to learn a balance and a fall recovery task by observing video demonstrations by amputee peers vs. non-amputees. The investigators will compare which setting produce better learning.

Eligibility Criteria

Inclusion Criteria: * 1\) have unilateral lower limb amputation, * 2\) age \>18 years, * 3\) are properly fitted with a walking prosthesis and use it regularly with at least moderate proficiency (K-2 level or above, further defined as scoring greater than 50 percentile on the Prosthetic Limb Users Survey of Mobility), * 4\) able to stand for at least 5 minutes without using an assistive device or experiencing excessive fatigue, * 5\) willing to travel to UNLV 6 times for training and testing. Exclusion Criteria: * 1\) have other concurrent central nervous system diseases that influence motor function and balance, * 2\) have leg/foot ulcer or other conditions that cause pain during weight-bearing, * 3\) have cardiovascular, respiratory or other critical health conditions that preclude moderate physical activity.

Contact & Investigator

Central Contact

Szu-Ping Lee, PhD

✉ szu-ping.lee@unlv.edu

📞 702-895-3086

Principal Investigator

Szu-Ping Lee, PhD

PRINCIPAL INVESTIGATOR

University of Nevada, Las Vegas

Frequently Asked Questions

Who can join the NCT06638723 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06638723 currently recruiting?

Yes, NCT06638723 is actively recruiting participants. Contact the research team at szu-ping.lee@unlv.edu for enrollment information.

Where is the NCT06638723 trial being conducted?

This trial is being conducted at Las Vegas, United States.

Who is sponsoring the NCT06638723 clinical trial?

NCT06638723 is sponsored by University of Nevada, Las Vegas. The principal investigator is Szu-Ping Lee, PhD at University of Nevada, Las Vegas. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology